SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-001642
Filing Date
2017-06-22
Accepted
2017-06-22 08:30:43
Documents
5
Period of Report
2017-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rennova_8k-062117.htm 8-K 30463
2 SECURITIES PURCHASE AGREEMENT rennova_ex-10139.htm EX-10.139 278557
3 ORIGINAL ISSUE DISCOUNT DEBENTURE rennova_ex-10140.htm EX-10.140 68322
4 COMMON STOCK PURCHASE WARRANT rennova_ex-10141.htm EX-10.141 98751
5 SUBSIDIARY GUARANTEE rennova_ex-10142.htm EX-10.142 90709
  Complete submission text file 0001683168-17-001642.txt   568174
Mailing Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401 561-855-1626
Rennova Health, Inc. (Filer) CIK: 0000931059 (see all company filings)

IRS No.: 680370244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35141 | Film No.: 17924073
SIC: 8734 Services-Testing Laboratories